James M. Brewer mainly investigates Immunology, Antigen, In vivo, Immune system and Cell biology. His research ties Alum and Immunology together. James M. Brewer studied Antigen and Antibody that intersect with Lymph node and Oral administration.
In his study, Acquired immune system, Heterologous, Immune tolerance, Secondary infection and Antigen-presenting cell is inextricably linked to Hemozoin, which falls within the broad field of Immune system. The various areas that James M. Brewer examines in his Cell biology study include Cell culture, T cell, IL-2 receptor, T-cell receptor and Macrophage. He interconnects Cytotoxic T cell and T lymphocyte in the investigation of issues within T cell.
His primary areas of study are Immunology, Immune system, Antigen, T cell and In vivo. His study in the fields of Acquired immune system under the domain of Immune system overlaps with other disciplines such as Context. His Antigen study which covers Vesicle that intersects with Pulmonary surfactant.
His T cell research incorporates themes from Dendritic cell, Priming, B cell and Cell biology. His research in Cell biology intersects with topics in Immunological synapse, T lymphocyte and CD8. His research integrates issues of In vitro and Pathology in his study of In vivo.
James M. Brewer focuses on Immunology, Immune system, T cell, Cell biology and In vivo. James M. Brewer has researched Immunology in several fields, including Disease and Trypanosoma brucei. His Immune system research is multidisciplinary, relying on both Inflammation, Virus, Antibody and Cytokine.
His work carried out in the field of T cell brings together such families of science as Cytotoxic T cell, Dendritic cell and Priming. His research integrates issues of Cyclin-dependent kinase, CDC2 Protein Kinase, Genetics and Cell cycle checkpoint in his study of Cell biology. His In vivo research focuses on Pathology and how it relates to Pinna.
Immune system, Pathology, Immunology, Antigen presentation and Cell biology are his primary areas of study. His research investigates the link between Immune system and topics such as Lymphatic system that cross with problems in Lymphotoxin, Lymphotoxin beta receptor, Myocyte and Mesenteric lymph nodes. In general Immunology, his work in Inflammatory arthritis and Antigen is often linked to Receptor tyrosine kinase linking many areas of study.
His Antigen presentation research is within the category of T cell. His T cell research is multidisciplinary, incorporating perspectives in Intraperitoneal injection, Meningoencephalitis, Dendritic cell and Lymphocyte. His studies deal with areas such as Cyclin-dependent kinase 1, Cyclin-dependent kinase and Perivascular space as well as Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reversal of the TCR stop signal by CTLA-4.
Helga Schneider;Helga Schneider;Jos Downey;Andrew Smith;Bernd H. Zinselmeyer;Bernd H. Zinselmeyer.
MHCII-Mediated Dialog between Group 2 Innate Lymphoid Cells and CD4+ T Cells Potentiates Type 2 Immunity and Promotes Parasitic Helminth Expulsion
Christopher J. Oliphant;You Yi Hwang;Jennifer A. Walker;Maryam Salimi.
Aluminium Hydroxide Adjuvant Initiates Strong Antigen-Specific Th2 Responses in the Absence of IL-4- or IL-13-Mediated Signaling
James M. Brewer;Margaret Conacher;Christopher A. Hunter;Markus Mohrs.
Journal of Immunology (1999)
How) do aluminium adjuvants work
James M Brewer.
Immunology Letters (2006)
In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.
James M. Brewer;Margaret Conacher;Abhay Satoskar;Horst Bluethmann.
European Journal of Immunology (1996)
Antigen depot is not required for alum adjuvanticity
Sharon Hutchison;Robert A. Benson;Vivienne B. Gibson;Abigail H. Pollock.
The FASEB Journal (2012)
Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function.
Owain R Millington;Owain R Millington;Caterina Di Lorenzo;R Stephen Phillips;Paul Garside;Paul Garside.
Journal of Biology (2006)
Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)
Margaret Conacher;James Alexander;James M. Brewer.
Lipid Vesicle Size Determines the Th1 or Th2 Response to Entrapped Antigen
James M. Brewer;Laurence Tetley;James Richmond;Foo Y. Liew.
Journal of Immunology (1998)
Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro.
Hongfan Sun;Kevin G.J. Pollock;James M. Brewer.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: